Majority Of Americans Would Consider Participating In An Alzheimer’s Clinical Trial. So, Why Are Enrollment Numbers So Low?

Global Alzheimer’s Platform (GAP) Foundation is promoting innovative and easier-to-use clinical trial participation tools, including the Brain Health Registry

WASHINGTON, D.C. – In a first-ever poll conducted online by Harris Poll on behalf of the Global Alzheimer’s Platform (GAP) Foundation, nearly 60% of Americans report they are definitely willing or would consider participating in Alzheimer’s disease clinical trials, but participation rates show that less than 10% are actually doing so (source). The failure to provide willing Americans more information and easier-to-use tools for participation could be seen as weakening the attack on America’s most feared disease (source).

Read the full release here.